What Amylyx Pharmaceuticals, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 2 |
| Sells | 11 | 31 |
| Total trades | 18 | 50 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 236,976 | 1,413,246 |
| Disposed | 121,302 | 591,975 |
| Net activity | +115,674 | +821,271 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Milne George M Jr | Director | Oct 05 | Open-market sale · S | −30,000 | $27.70 | −$831K | 782,881 |
| Frates James M | Chief Financial Officer | Sep 10 | Open-market sale · S | −1,042 | $33.23 | −$34.6K | 233,625 |
| Frates James M | Chief Financial Officer | Sep 10 | Open-market sale · S | −9,768 | $32.27 | −$315K | 234,667 |
| Klee Justin B. | Co-Chief Executive Officer | Sep 10 | Open-market sale · S | −1,439 | $33.16 | −$47.7K | 3,613,056 |
| Klee Justin B. | Co-Chief Executive Officer | Sep 10 | Open-market sale · S | −29,025 | $32.13 | −$933K | 3,614,495 |
| Cohen Joshua B | Co-Chief Executive Officer | Sep 10 | Open-market sale · S | −919 | $33.15 | −$30.5K | 3,613,123 |
| Cohen Joshua B | Co-Chief Executive Officer | Sep 10 | Open-market sale · S | −29,545 | $32.16 | −$950K | 3,614,042 |
| Bedrosian Camille L | Chief Medical Officer | Sep 10 | Open-market sale · S | −2,081 | $33.09 | −$68.9K | 278,064 |
| Bedrosian Camille L | Chief Medical Officer | Sep 10 | Open-market sale · S | −7,947 | $32.21 | −$256K | 280,145 |
| Mazzariello Gina | Chief Legal Officer | Sep 10 | Open-market sale · S | −11 | $33.34 | −$367 | 190,838 |
| Mazzariello Gina | Chief Legal Officer | Sep 10 | Open-market sale · S | −9,525 | $32.46 | −$309K | 190,849 |
| Firestone Karen | Director | Aug 31 | Exercise / conversion · M | +25,000 | $5.05 | +$126K | 116,900 |
| Firestone Karen | Director | Aug 31 | Exercise / conversion · M | +25,000 | $1.76 | +$44K | 91,900 |
| Klee Justin B. | Co-Chief Executive Officer | Aug 18 | Grant / award · A | +60,039 | — | — | 3,643,520 |
| Frates James M | Chief Financial Officer | Aug 18 | Grant / award · A | +22,807 | — | — | 244,435 |
| Mazzariello Gina | Chief Legal Officer | Aug 18 | Grant / award · A | +21,284 | — | — | 200,374 |
| Bedrosian Camille L | Chief Medical Officer | Aug 18 | Grant / award · A | +22,807 | — | — | 288,092 |
| Cohen Joshua B | Co-Chief Executive Officer | Aug 18 | Grant / award · A | +60,039 | — | — | 3,643,587 |
| Mazzariello Gina | Chief Legal Officer | Jul 10 | Open-market sale · S | −15,000 | $17.61 | −$264K | 179,090 |
| Mazzariello Gina | Chief Legal Officer | Jul 09 | Open-market sale · S | −15,000 | $18.32 | −$275K | 194,090 |
Loading...
